Chemical synthesis and biological evaluation of novel epothilone B and trans-12,13-cyclopropyl epothilone B analogues

被引:47
作者
Nicolaou, KC
Ritzén, A
Namoto, K
Buey, RM
Díaz, JF
Andreu, JM
Wartmann, M
Altmann, KH
O'Brate, A
Giannakakou, P
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
[4] Novartis Pharma AG, Corp Res, CH-4002 Basel, Switzerland
[5] Novartis Pharma AG, Oncol Business Unit, CH-4002 Basel, Switzerland
[6] CSIC, Ctr Invest Biol, Madrid 20006, Spain
[7] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
epothilones; antitumor agents; chemical synthesise; structure-activity relationships;
D O I
10.1016/S0040-4020(02)00655-5
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In addition to the total synthesis of the thiomethyl thiazole side chain analogue of epothilone B (3), a series of related trans-12,13-cyclopropyl epothilone B analogues (6, 8, 10, 12-14) was accomplished. While the synthesis of the epothilone B analogue (3) proceeded through a Stille coupling of a vinyl iodide substrate containing the epothilone macrocycle with the appropriate side chain stannane, that of the cyclopropyl analogues (6, 8, 10, 12-14) involved a convergent strategy in which a Nozaki-Hiyama-Kishi coupling as a means of introducing the side chains prior to Yamaguchi macrolactonization and final elaboration to the target molecules. The synthesized analogues were subjected to biological evaluation involving in vitro tubulin polymerization, affinity for the microtubule Taxol(R) binding site and cell cytotoxicity assays. The results identified the methylthio thiazole side chain as a potency enhancing moiety for the epothilones and shed further light on the structure-activity relationships within this important class of chemotherapeutic agents. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:6413 / 6432
页数:20
相关论文
共 34 条
[21]  
Nicolaou KC, 2000, CHEM-EUR J, V6, P2783, DOI 10.1002/1521-3765(20000804)6:15<2783::AID-CHEM2783>3.0.CO
[22]  
2-B
[23]   Total synthesis of epothilone E and related side-chain modified analogues via a Stille coupling based strategy [J].
Nicolaou, KC ;
King, NP ;
Finlay, MRV ;
He, Y ;
Roschangar, F ;
Vourloumis, D ;
Vallberg, H ;
Sarabia, F ;
Ninkovic, S ;
Hepworth, D .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (05) :665-697
[24]   Chemical synthesis and biological evaluation of cis- and trans-12,13-cyclopropyl and 12,13-cyclobutyl epothilones and related pyridine side chain analogues [J].
Nicolaou, KC ;
Namoto, K ;
Ritzén, A ;
Ulven, T ;
Shoji, M ;
Li, J ;
D'Amico, G ;
Liotta, D ;
French, CT ;
Wartmann, M ;
Altmann, KH ;
Giannakakou, P .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (38) :9313-9323
[25]  
Nicolaou KC, 2001, CHEMBIOCHEM, V2, P69
[26]   Recent developments in the chemistry, biology and medicine of the epothilones [J].
Nicolaou, KC ;
Ritzén, A ;
Namoto, K .
CHEMICAL COMMUNICATIONS, 2001, (17) :1523-1535
[27]   Designed epothilones: Combinatorial synthesis, tubulin assembly properties, and cytotoxic action against taxol-resistant tumor cells [J].
Nicolaou, KC ;
Vourloumis, D ;
Li, TH ;
Pastor, J ;
Winssinger, N ;
He, Y ;
Ninkovic, S ;
Sarabia, F ;
Vallberg, H ;
Roschangar, F ;
King, NP ;
Finlay, MRV ;
Giannakakou, P ;
VerdierPinard, P ;
Hamel, E .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1997, 36 (19) :2097-2103
[28]   Total syntheses of epothilones A and B via a macrolactonization-based strategy [J].
Nicolaou, KC ;
Ninkovic, S ;
Sarabia, F ;
Vourloumis, D ;
He, Y ;
Vallberg, H ;
Finlay, MRV ;
Yang, Z .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (34) :7974-7991
[29]  
Sinha SC, 2001, CHEMBIOCHEM, V2, P656, DOI 10.1002/1439-7633(20010903)2:9<656::AID-CBIC656>3.0.CO
[30]  
2-3